Randomized clinical study of five days apostrophe therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis in children

World Journal of Gastroenterology

Volumn 12, Issue 39, 2006, Pages 6366-6370

  Cañete, Roberto ^a   Escobedo, Angel A ^b,e   González, María E ^c   Almirall, Pedro ^d  

^a Hygiene Epidemiology and Microbiology Centre   (Cuba)

^b Academic Paediatric Hospital Pedro Borras   (Cuba)

^c INSTITUTO DE GASTROENTEROLOGÍA   (Cuba)

^d INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^e Hospital Pediatrico Universitario Pedro Borras   (Cuba)

Author keywords

Benzimidazoles therapeutic use; Children; Cuba; Giardia infection drug therapy; Giardiasis drug therapy; Mebendazole therapeutic use; Quinacrine therapeutic use

Indexed keywords

MEBENDAZOLE; MEPACRINE;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; FECES ANALYSIS; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; GIARDIA DUODENALIS; GIARDIASIS; HUMAN; INTESTINE INFECTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; RANDOMIZED CONTROLLED TRIAL; SKIN DISCOLORATION; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; VOMITING;

EID: 33750804205     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i39.6366     Document Type: Article

References (31)

1. Adam RD. Biology of Giardia lamblia. Clin Microbiol Rev 2001; 14: 447-475
2. Ortega YR, Adam RD. Giardia: overview and update. Clin Infect Dis 1997; 25: 545-349; quiz 550
3. Taylor GD, Wenman WM, Tyrrell DL. Combined metronidazole and quinacrine hydrochloride therapy for chronic giardiasis. CMAJ 1987; 136: 1179-1180
4. Nash TE, Ohl CA, Thomas E, Subramanian G, Keiser P, Moore TA. Treatment of patients with refractory giardiasis. Clin Infect Dis 2001; 33: 22-28
5. Rodriguez-Garcia R, Rodriguez-Guzman LM, Cruz del Castillo AH. Effectiveness and safety of mebendazole compared to nitazoxanide in the treatment of Giardia lamblia in children. Rev Gastroenterol Mex 1999; 64: 122-126
6. Fox LM, Saravolatz LD. Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis 2005; 40: 1173-1180
7. Escobedo AA, Nunez FA, Moreira I, Vega E, Pareja A, Almirall P. Comparison of chloroquine, albendazole and tinidazole in the treatment of children with giardiasis. Ann Trop Med Parasitol 2003; 97: 367-371
8. Edlind TD, Hang TL, Chakraborty PR. Activity of the anthelmintic benzimidazoles against Giardia lamblia in vitro. J Infect Dis 1990; 162: 1408-1411
9. Katelaris PH, Naeem A, Farthing MJ. Activity of metronidazole, azithromycin and three benzimidazoles on Giardia lamblia growth and attachment to a human intestinal cell line. Aliment Pharmacol Ther 1994; 8: 187-192
10. Cedillo-Rivera R, Munoz O. In-vitro susceptibility of Giardia lamblia to albendazole, mebendazole and other chemotherapeutic agents. J Med Microbiol 1992; 37: 221-224
11. Morgan UM, Reynoldson JA, Thompson RC. Activities of several benzimidazoles and tubulin inhibitors against Giardia spp. in vitro. Antimicrob Agents Chemother 1993; 37: 328-331
12. Chavez B, Cedillo-Rivera F. Martinez-Palomo A. Giardia lamblia: ultrastructural study of the in vitro effect of benzimidazoles. J Protozool 1992; 39: 510-515
13. Katiyar SK, Gordon VR, McLaughlin GL, Edlind TD. Anti-protozoal activities of benzimidazoles and correlations with beta-tubulin sequence. Antimicrob Agents Chemother 1994; 38: 2086-2090
14. MacDonald LM, Armson A, Thompson AR, Reynoldson JA. Characterisation of benzimidazole binding with recombinant tubulin from Giardia duodenalis, Encephalitozoon intestinalis, and Cryptosporidium parvum. Mol Biochem Parasitol 2004; 138: 89-96
15. al-Waili NS, al-Waili BH, Saloom KY. Therapeutic use of mebendazole in giardial infections. Trans R Soc Trop Med Hyg 1988; 82: 438
16. Sadjjadi SM, Alborzi AW, Mostovfi H. Comparative clinical trial of mebendazole and metronidazole in giardiasis of children. J Trop Pediatr 2001; 47: 176-178
17. Escobedo AA, Canete R, Gonzalez ME, Pareja A, Cimerman S, Almirall P. A randomized trial comparing mebendazole and secnidazole for the treatment of giardiasis. Ann Trop Med Parasitol 2003; 97: 499-504
18. García LS, Bruckner DA. Diagnostic Medical Parasitology. Macroscopic and Microscopic Examination of fecal specimens. American Society for Microbiology. Washington: DC, 1993: 501-540
19. Armitage P, Berry G. Statistical Methods in Medical Research, 2nd ed. Oxford: Blackwell Scientific, 1987
20. Hutchison JG, Johnston NM, Plevey MV, Thangkhiew I, Aidney C. Clinical trial of mebendazole, a broad-spectrum anthelminthic. Br Med J 1975; 2: 309-310
21. Gascon J, Moreno A, Valls ME, Miro JM, Corachan M. Failure of mebendazole treatment in Giardia lamblia infection. Trans R Soc Trop Med Hyg 1989; 83: 647
22. di Martino L, Nocerino A, Mantovani MP. Mebendazole in giardial infections: confirmation of the failure of this treatment. Trans R Soc Trop Med Hyg 1991; 85: 557-558
23. Rousham EK. An increase in Giardia duodenalis infection among children receiving periodic Anthelmintic treatment in Bangladesh. J Trop Pediatr 1994; 40: 329-333
24. Bulut BU, Gulnar SB, Aysev D. Alternative treatment protocols in giardiasis: a pilot study. Scand J Infect Dis 1996; 28: 493-495
25. Wolfe MS. Giardiasis. Clin Microbiol Rev 1992; 5: 93-100
26. Gardner TB, Hill DR. Treatment of giardiasis. Clin Microbiol Rev 2001; 14: 114-128
27. Gillin FD, Diamond LS. Inhibition of clonal growth of Giardia lamblia and Entamoeba histolytica by metronidazole, quinacrine, and other antimicrobial agents. J Antimicrob Chemother 1981; 8: 305-316
28. Genel F, Erermis S, Aksu G, Ozturk C, Kutukculer N. Quinacrine-induced psychiatric disturbances in a child with common variable immunodeficiency and chronic giardiasis. Hum Psychopharmacol 2002; 17: 357-359
29. Smith PD, Gillin FD, Spira WM, Nash TE. Chronic giardiasis: studies on drug sensitivity, toxin production, and host immune response. Gastroenterology 1982; 83: 797-803
30. Upcroft JA, Campbell RW, Upcroft P. Quinacrine-resistant Giardia duodenalis. Parasitology 1996; 112 (Pt 3): 309-313
31. Bircher J. Clinical pharmacology of benzimidazole anthelmintics administered for systemic effects. XXI Congreso Internacional de Hidatología, Madrid, Spain, 24-27 April 1985